Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants
Authors:
- Anne SchuindASAnne Schuind
- Markus KnufMKMarkus Knuf
- Karin BeutelKBKarin Beutel
- Hermann Schulte-WissermannHSHermann Schulte-Wissermann
- Manfred GahrMGManfred Gahr
- Rainer SchultRSRainer Schult
- Jens FolkensJFJens Folkens
- Wolfgang RauhWRWolfgang Rauh
- Hugues BogaertsHBHugues Bogaerts
- Hans L. BorkHBHans L. Bork
- Ralf ClemensRCRalf Clemens
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 129 (5) , 695-701
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prenatal Etiologies of West SyndromeEpilepsia, 1993
- Acellular Pertussis Vaccines—A Solution to the Pertussis Problem?The Journal of Infectious Diseases, 1993
- Pertussis immunization and characteristics related to first seizures in infants and childrenThe Journal of Pediatrics, 1993
- Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in childrenEuropean Journal of Pediatrics, 1993
- Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of ageThe Lancet, 1992
- Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infantsThe Journal of Pediatrics, 1991
- Development of an acellular pertussis vaccine and its administration as a booster in healthy adultsVaccine, 1991
- Pertussis vaccine and injury to the brainThe Journal of Pediatrics, 1990
- Natural History of Pertussis Antibody in the Infant and Effect on Vaccine ResponseThe Journal of Infectious Diseases, 1990
- DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPANThe Lancet, 1984